Skip to content
ViiV Healthcare
-
Vir expands partnership with Gates Foundation to develop HIV and malaria antibody
USA – Vir Biotechnology and the Bill & Melinda Gates Foundation have collaborated to develop broadly neutralizing antibodies with a vaccinal effect for HIV treatment…
-
Huge blow to Gilead’s and Merck’s HIV strategy as safety concerns mar once-weekly HIV drug combination
USA – Gilead Sciences, Inc. and Merck have temporarily suspended enrollment in a Phase 2 clinical study evaluating an investigational once-weekly oral combination treatment regimen…
-
ViiV Healthcare partners with Japan’s Shionogi to develop longer-acting HIV drug
USA – ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline (GSK) has agreed to collaborate with Shionogi on the development of ultra-long…
-
Enhanze drug delivery technology brings ViiV Healthcare and Halozyme into a collaboration
UK – ViiV Healthcare, a global specialist HIV that is majorly owned by GlaxoSmithKline plc have announced a global collaboration and license agreement that gives…